SEC 13F Intelligence

Managers / Q2 2019 · view latest →

MASO CAPITAL PARTNERS Ltd

CIK 0001698093 · 8/F PRINTING HOUSE, 6 DUDDELL STREET, HONG KONG, 000000 · 852 34686200

Reported Value
$191M
Q2 2019
Positions
19
Filings on Record
30
2019–present window
Filed
Aug 13, 2019
original filing

Summary

Maso Capital Partners Ltd reported $191M in U.S.-listed holdings across 19 positions for Q2 2019.

The portfolio is heavily concentrated: CELG alone accounts for 26.0% of reported value.

Compared with Q1 2019, the fund opened 6 new positions and exited 3.

Portfolio Metrics

Turnover
+25.0%
vs prior filed quarter
Top-10 Concentration
+88.2%
share of reported value
Largest Position
+26.0%
Celgene
New / Exited
6 / 3
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $80MQ4 ’18Q1 ’19: $145MQ2 ’19: $191MQ3 ’19: $278MQ4 ’19: $311MQ4 ’19Q1 ’20: $386MQ2 ’20: $248MQ3 ’20: $179MQ4 ’20: $367MQ4 ’20Q1 ’21: $260MQ2 ’21: $304MQ3 ’21: $222MQ4 ’21: $218MQ4 ’21Q1 ’22: $246MQ2 ’22: $177MQ3 ’22: $429MQ1 ’23: $150,581Q1 ’23Q2 ’23: $228,000Q3 ’23: $183,560Q4 ’23: $115,713Q1 ’24: $135,260Q1 ’24Q3 ’24: $107MQ4 ’24: $79MQ1 ’25: $66MQ2 ’25: $57MQ2 ’25Q3 ’25: $61Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 57.5%Other: 19.0%MLP: 14.1%ADR: 9.4%
  • Common Stock · 57.5% · $110M
  • Other · 19.0% · $36M
  • MLP · 14.1% · $27M
  • ADR · 9.4% · $18M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
BPLUSDBUCKEYE PARTNERS LPNEW+653.3K653.3K+$27M$27M
YY INCNEW+3.00M3.00M+$3M$3M
HUYAHUYA INCNEW+68.8K68.8K+$2M$2M
YY INCNEW+1.50M1.50M+$2M$2M
BYNDBEYOND MEAT INCNEW+6.6K6.6K+$1M$1M
HCMUSDHUTCHISON CHINA MEDITECH LTDNEW+45.0K45.0K+$990,000$990,000
CELGCELGENE CORPADDED+369.5K537.0K+$34M$50M
BEMIS CO INCSOLD OUT−472.8K0−$26M$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2019

17 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1CELGCELGENE CORPhistory →COM26.04%$50M537.0K
2RHT1EURRED HAT INChistory →COM18.82%$36M191.1K
3BPLUSDBUCKEYE PARTNERS LPhistory →UNIT LTD PARTN14.06%$27M653.3K
4CHINA BIOLOGIC PRODS HLDGS ICOM7.55%$14M151.0K
5GNWGENWORTH FINL INChistory →COM CL A5.74%$11M2.95M
6BUNGE LIMITEDCOM4.45%$8M152.3K
7YUMCYUM CHINA HLDGS INChistory →COM3.88%$7M160.0K
8CYOUUSDCHANGYOU COM LTDhistory →ADS REP CL A2.82%$5M558.8K
9ACHCACADIA HEALTHCARE COMPANY INhistory →COM2.52%$5M137.4K
10YY INCDEBT 1.375% 6/1 · DEBT 0.750% 6/12.39%$5M4.50M
11SOHUSOHU COM LTDhistory →SPONSORED ADS2.35%$4M319.8K
12MELCO RESORTS AND ENTMT LTDADR1.65%$3M144.5K
13TAKEDA PHARMACEUTICAL CO LTDSPONSORED ADS1.19%$2M127.8K
14HUYAHUYA INCADS REP SHS A0.89%$2M68.8K
15BYNDBEYOND MEAT INCCOM0.56%$1M6.6K
16HCMUSDHUTCHISON CHINA MEDITECH LTDSPONSORED ADR0.52%$990,00045.0K
17NAKED BRAND GROUP LIMITEDORD SHS0.15%$288,0002.12M

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2025$61M44Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$57M29Aug 18, 202513F-HRchanges · EDGAR ↗
Q1 2025$66M34May 9, 202513F-HRchanges · EDGAR ↗
Q4 2024$79M34Feb 12, 202513F-HRchanges · EDGAR ↗
Q3 2024$107M36Nov 4, 202413F-HRchanges · EDGAR ↗
Q2 2024Under review28Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$135,26036May 10, 202413F-HRchanges · EDGAR ↗
Q4 2023$115,71327Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$183,56037Nov 13, 202313F-HRchanges · EDGAR ↗
Q2 2023$228,00037Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$150,58136May 11, 202313F-HRchanges · EDGAR ↗
Q4 2022Under review42Feb 13, 202313F-HRchanges · EDGAR ↗
Q3 2022REVEALED$429M60Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$177M61Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$246M56May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$218M47Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$222M41Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$304M54Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$260M47May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$367M45Feb 12, 202113F-HRchanges · EDGAR ↗
Q3 2020$179M21Nov 12, 202013F-HRchanges · EDGAR ↗
Q2 2020$248M22Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$386M21May 11, 202013F-HRchanges · EDGAR ↗
Q4 2019$311M20Feb 12, 202013F-HRchanges · EDGAR ↗
Q3 2019$278M19Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$191M19Aug 13, 201913F-HRchanges · EDGAR ↗
Q1 2019$145M16May 14, 201913F-HRchanges · EDGAR ↗
Q4 2018$80M10Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.